Section He-P 4035.71 - Training for Experienced Radiation Safety Officer, Teletherapy or Medical Physicist, Authorized Medical Physicist, Authorized User, Nuclear Pharmacist, and Authorized Nuclear Pharmacist(a) An individual identified as:(1) A radiation safety officer, a teletherapy or medical physicist, an authorized medical physicist, a nuclear pharmacist, or an authorized nuclear pharmacist on a DHHS/RHS, or an agreement state, or a Nuclear Regulatory Commission license or a permit issued by DHHS/RHS, or a Nuclear Regulatory Commission broad scope licensee or master material license permit, or by a master material license permittee of broad scope before January 14, 2019, need not comply with the training requirements of He-P 4035.61, He-P 4035.70, or He-P 4035.74, respectively except the radiation safety officers and authorized medical physicists identified in He-P 4035.71(a)(1) shall meet the training requirements in He-P 4035.61(e) or He-P 4035.70(c), as appropriate, for any material or uses for which they were not authorized prior to this date;(2) An individual certified by the American Board of Health Physics in comprehensive health physics; American Board of Radiology; American Board of Nuclear Medicine; American Board of Science in Nuclear Medicine; Board of Pharmaceutical Specialties in Nuclear Pharmacy; American Board of Medical Physics in radiation oncology physics; Royal College of Physicians and Surgeons of Canada in nuclear medicine; American Osteopathic Board of Radiology; or American Osteopathic Board of Nuclear Medicine on or before October 24, 2005, need not comply with the training requirements of He-P 4035.61 to be identified as a radiation safety officer or as an associate radiation safety officer on a DHHS/RHS, an agreement state, or Nuclear Regulatory Commission license or Nuclear Regulatory Commission master material license permit for those materials and uses that these individuals performed on or before October 24, 2005; or(3) An individual certified by the American Board of Radiology in therapeutic radiological physics, Roentgen ray and gamma ray physics, x-ray and radium physics, or radiological physics, or certified by the American Board of Medical Physics in radiation oncology physics, on or before October 24, 2005, need not comply with the training requirements for an authorized medical physicist described in He-P 4035.70, for those materials and uses that these individuals performed on or before October 24, 2005.(b) Physicians, dentists, or podiatrists identified as authorized users for the medical use of byproduct material on a license issued by the DHHS/RHS, an agreement state, or the Nuclear Regulatory Commission, or a permit issued by a Nuclear Regulatory Commission master material licensee, a permit issued by the DHHS/RHS, or an agreement state, or the Nuclear Regulatory Commission broad scope licensee, or a permit issued by a Nuclear Regulatory Commission master material license broad scope permittee before January 14, 2019, who perform only those medical uses for which they were authorized on that date need not comply with the training requirements of He-P 4035 subparts equivalent to 10 CFR 35 Subparts D through H.(c) Physicians, dentists, or podiatrists not identified as authorized users for the medical use of byproduct material on a license issued by DHHS/RHS, an agreement state, or the Nuclear Regulatory Commission, or a permit issued by a Nuclear Regulatory Commission master material licensee, a permit issued by DHHS/RHS, an agreement state, or Nuclear Regulatory Commission broad scope licensee, or a permit issued by a Nuclear Regulatory Commission master material license of broad scope on or before October 24, 2005, need not comply with the training requirements of He-P 4035 subparts equivalent to 10 CFR 35 Subparts D through H for those materials and uses that these individuals performed on or before October 24, 2005, as follows:(1) For uses authorized under He-P 4035.27 or He-P 4035.31, or oral administration of sodium iodide I-131 requiring a written directive for imaging and localization purposes, a physician who was certified on or before October 24, 2005, in nuclear medicine by the American Board of Nuclear Medicine; diagnostic radiology by the American Board of Radiology; diagnostic radiology or radiology by the American Osteopathic Board of Radiology; nuclear medicine by the Royal College of Physicians and Surgeons of Canada; or American Osteopathic Board of Nuclear Medicine in nuclear medicine;(2) For uses authorized under He-P 4035.35, a physician who was certified on or before October 24, 2005, by the American Board of Nuclear Medicine; the American Board of Radiology in radiology, therapeutic radiology, or radiation oncology; nuclear medicine by the Royal College of Physicians and Surgeons of Canada; or the American Osteopathic Board of Radiology after 1984;(3) For uses authorized under He-P 4035.41 or He-P 4035.47, a physician who was certified on or before October 24, 2005, in radiology, therapeutic radiology or radiation oncology by the American Board of Radiology; radiation oncology by the American Osteopathic Board of Radiology; radiology, with specialization in radiotherapy, as a British "Fellow of the Faculty of Radiology" or "Fellow of the Royal College of Radiology"; or therapeutic radiology by the Canadian Royal College of Physicians and Surgeons; and(4) For uses authorized under He-P 4035.39, a physician who was certified on or before October 24, 2005, in radiology, diagnostic radiology, therapeutic radiology, or radiation oncology by the American Board of Radiology; nuclear medicine by the American Board of Nuclear Medicine; diagnostic radiology or radiology by the American Osteopathic Board of Radiology; or nuclear medicine by the Royal College of Physicians and Surgeons of Canada.(d) Physicians, dentists, or podiatrists who used only accelerator-produced radioactive materials, discrete sources of radium-226, or both, for medical uses performed at locations of use before August 8, 2009, or an earlier date as noticed by DHHS/RHS, need not comply with the training requirements of He-P 4035 subparts equivalent to 10 CFR 35 Subparts D through H when performing the same medical uses. A physician, dentist, or podiatrist, who used only accelerator-produced radioactive materials, discrete sources of radium-226, or both, for medical uses at the locations and time period identified in this paragraph, qualifies as an authorized user for those materials and uses performed before these dates, for the purposes of He-P 4035.(e) Individuals who need not comply with training requirements as described in He-P 4035.71(a) through (d) above may serve as preceptors for, and supervisors of, applicants seeking authorization on DHHS/RHS licenses for the same uses for which these individuals are authorized.N.H. Admin. Code § He-P 4035.71
(See Revision Note at part heading for He-P 4035) #6942, eff 2-1-99; ss by #8800, INTERIM, eff 2-1-07, EXPIRED: 7-31-07
New. #8959, eff 8-7-07
Amended by Volume XXXV, Number 32 Filed August 13, 2015, Proposed by #10897, Effective 7/22/2015, Expires1/18/2016.Amended by Volume XXXVI Number 01, Filed January 7, 2016, Proposed by #11011, Effective 1/15/2016, Expires 1/15/2026.Amended by Volume XL Number 24, Filed June 11, 2020, Proposed by #13048, Effective 6/2/2020, Expires 6/2/2030.